Firms
Theme

AI

C3.ai, Inc. · NYSE

News

11 latest

Zacks Investment Research

C3.ai, Inc. (AI) Dips More Than Broader Market: What You Should Know

C3.ai, Inc. (AI) closed at $11.33, down 6.83% in the latest session, underperforming the broader market. While the stock gained 12.8% over the past month, upcoming earnings show projected revenue declining 29.34% quarter-over-quarter and 10.89% year-over-year. The company holds a Zacks Rank #3 (Hold) rating with a consensus EPS estimate of -$0.22 for the quarter.

Zacks Investment Research

Can BigBear.ai Ride the Next Wave of Defense Technology?

BigBear.ai is capitalizing on defense AI opportunities through its Ask Sage platform and ConductorOS autonomous systems, securing over 20 contracts and growing its backlog to $269.6M. However, the company faces profitability headwinds with a $25.7M net loss and widening EBITDA losses, while competing against stronger rivals like Palantir and C3.ai in the defense AI space.

Zacks Investment Research

BigBear.ai Trades at a Discount to Industry: Buy the Stock or Hold?

BigBear.ai (BBAI) secured over 20 new contracts in Q2 2026, growing its backlog 9% to $269.6M, but faces persistent profitability challenges with adjusted EBITDA losses widening to $11.6M despite 13% revenue growth. The company's strong liquidity ($409.8M) and AI portfolio expansion offer potential, but intense competition, government contract dependence, and share dilution pose significant risks. Analysts maintain a cautious Hold rating pending clearer evidence of sustainable profitability.

Zacks Investment Research

Is Palantir's AIP Platform Fueling Explosive U.S. Commercial Growth?

Palantir Technologies reported exceptional growth in its U.S. commercial business during Q2 2026, with revenues surging 149% year-over-year to $764 million, driven by increasing enterprise adoption of its AI Platform (AIP). The company added 35% more customers to reach 653 and saw total contract value jump 153% to $2.13 billion. However, the stock trades at a premium valuation of 45.79X forward price-to-sales, well above industry average, and faces intensifying competition from peers like Snowflake and C3.ai in the enterprise AI space.

Zacks Investment Research

C3.ai, Inc. (AI) is Attracting Investor Attention: Here is What You Should Know

C3.ai (AI) has attracted investor attention with a +3.9% return over the past month. However, the company faces headwinds including declining revenues (-29.3% YoY for current quarter) and a Zacks Rank #3 (Hold) rating. While earnings estimates show improvement with expected profitability next fiscal year, the stock is trading at a premium valuation relative to peers.

The Motley Fool

C3.ai vs. UiPath: Which AI-Driven Tech Stock Is a Better Buy in 2026?

The article compares C3.ai and UiPath as investments in the agentic AI automation space. UiPath is recommended as the better buy due to its profitability, positive free cash flow, and consistent growth trajectory. C3.ai, while showing recent improvements like positive free cash flow and 73% quarter-over-quarter booking growth, remains unprofitable with substantial net losses and is still in early restructuring stages under CEO Thomas Siebel.

Zacks Investment Research

Why C3.ai, Inc. (AI) Outpaced the Stock Market Today

C3.ai, Inc. (AI) closed at $11.53, up 1.68% in the latest session, outperforming the S&P 500's 0.6% gain. The stock has gained 8.31% over the past month.

Zacks Investment Research

Can BigBear.ai Build Stronger Growth Heading Into 2027?

BigBear.ai (BBAI) reported Q2 2026 revenues up 13% year-over-year to $36.7M with gross margins expanding to 32.8%, and secured over 20 contracts lifting backlog to $269.6M. However, adjusted EBITDA losses widened to $11.6M, and the stock has declined 27.1% over six months. The company faces competition from Palantir and C3.ai in defense AI solutions but maintains a strong $409.8M cash position for potential acquisitions.

Zacks Investment Research

C3.ai, Inc. (AI) Is a Trending Stock: Facts to Know Before Betting on It

C3.ai (AI) has been a trending stock with a Zacks Rank #3 (Hold) rating. While the company showed positive earnings estimate revisions and beat consensus estimates in recent quarters, it faces revenue headwinds with current quarter sales expected to decline 29.3% year-over-year. The stock trades at a premium valuation (F grade) compared to peers and is expected to perform in line with the broader market in the near term.

The Motley Fool

C3.ai CEO Thomas Siebel Sells Over 444,000 Shares Worth $4.8 Million After a 40% Decline in the Stock

C3.ai CEO Thomas Siebel sold approximately 444,000 shares worth $4.8 million on September 15-16, 2026, through a pre-established Rule 10b5-1 trading plan. The sale occurred after the stock declined 40% over the past year, though Siebel maintains millions of shares through direct and indirect holdings. Despite the stock decline during his health-related absence in 2025, the company showed signs of recovery with a 73% quarter-over-quarter increase in customer bookings after his return in June.

Mentions AI

Zacks Investment Research

Can Innodata's 7-Language Speech Opportunity Drive Revenue Growth?

Innodata is expanding its data-collection pipeline with a seven-language speech program and successful robotics pilots that could unlock a 2 million-hour egocentric data opportunity. The company's growth depends on converting these scoped programs into commercial engagements and scaling delivery. INOD stock has gained 30% YTD but trades at a premium valuation (P/S of 5.23) with a Zacks Rank #3 (Hold) rating.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AI · 0 threads

Sign in to post on $AI

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev